BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 16, Issue 11
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews
©The Author(s) 2024.
World J Hepatol. Nov 27, 2024; 16(11): 1243-1254
Published online Nov 27, 2024. doi: 10.4254/wjh.v16.i11.1243
Table 1 The contents of the combination therapy with albendazole
Treatment plan
In vitro or in vivo
Treatment effect
ABZ + ubenimexIn vitro + in vivoBetter therapeutic effect
ABZ + carvacrolIn vitro + in vivoBetter therapeutic effect
ABZ + metforminIn vitro + in vivoBetter therapeutic effect
ABZ + atovaquoneIn vitro + in vivoBetter therapeutic effect
ABZ + thymolIn vitro + in vivoBetter therapeutic effect
ABZ + 2-DGIn vitroBetter therapeutic effect
ABZ + nitazoxanideIn vitroHas a certain effect
ABZ + GIZnIn vitro + in vivoHas a certain effect
ABZ solubilizing agentsIn vitro + in vivoBetter therapeutic effect
ABZ: Albendazole; 2-DG: 2-deoxy-D-glucose; GIZn: Glucan supplemented with zinc.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.